Polymorphisms in the ABCB1 gene can affect clearance of the chemotherapeutic drugs docetaxel and irinotecan.
Docetaxel can be used to treat malignant tumors including:
(1) breast cancer
(2) non-small cell lung cancer
(3) metastatic prostate cancer
Irinotecan can be used to treat:
(1) metastatic colorectal cancer
The ABCB1 gene encodes MDR1 P-glycoprotein, which is a transporter for the adenosine triphosphate binding cassette (ABC).
A patient who is homozygous for the 1236C>T (C1236T) polymorphism of ABCB1 shows decreased clearance of these 2 drugs and their active metabolites compared to patients homozygous for the wild type or heterozygous for the polymorphism.
A patient who is homozygous for the 1236C>T polymorphism will have decreased clearance of doxetaxel or irinotecan. A usual dose of the drug may cause a toxic reaction. This can be avoided by administering a lower dose of the drug.
Purpose: To evaluate a patient who is about to undergo chemotherapy with either docetaxel or irinotecan for a polymorphism in the ABCB1 gene.
Specialty: Toxicology, Emergency Medicine, Critical Care, Genetics
Objective: laboratory tests, pharmacogenetics
ICD-10: C00-C14, C16, C18, C19, C20, C21, C34, C50-C50, C61,